Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS)-Reference-Cited by-同舟云学术

Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS)

Published:2002-10 Issue:7 Volume:90 Page:731-736
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Streja Leanne,Packard Chris J,Shepherd James,Cobbe Stuart,Ford Ian

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia;Shepherd;N Engl J Med,1995

2. Randomised trial of cholesterol lowering in 444 patients with coronary heart disease: the Scandanavian Simvastatin Survival Study (4S);Lancet,1994

3. Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia;Jeenah;Atherosclerosis,1993

4. Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy;Ordovas;Atherosclerosis,1995

5. Prevention of coronary heart disease by raising high density lipoprotein cholesterol?;Von Eckardstein;Curr Opin Lipidol,2000

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transporter Genes and statin-induced Hepatotoxicity;Cardiovascular Drugs and Therapy;2024-05-29

2. When the same treatment has different response: The role of pharmacogenomics in statin therapy;Biomedicine & Pharmacotherapy;2024-01

3. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29

4. Linking biological variation to outcomes of statin treatment in the general population;2023-03-21

5. Physiological and psychological effects of a 12-week home-based telemonitored training in metabolic syndrome;Frontiers in Cardiovascular Medicine;2023-01-10